Reporting Turn-Around Testing
Aurora Diagnostics Arizona Dermatopathology strives to deliver your pathology reports in one business day from the day the specimen was received in our laboratory.

Several variables may impact your turn-around testing. Reporting TAT’s vary in the method chosen to receive your reports. Mailed or hand-delivered reports may slightly increase the TAT as compared to electronic or direct reporting mechanisms.

Rarely, your office may experience a TAT delay for reasons outside of our control, such as, hazardous weather conditions experienced by our Courier(s) (UPS/FedEx).

If testing results are needed and your office has not received the pathology report, please call one of our Medical Data Specialists at 480.275.2494 Option 2.

Confidentiality of Results
ADX Arizona Dermatopathology strives to maintain the confidentiality of all patient information. To ensure the appropriate release of patient results in response to a telephone inquiry, at least one of the following may be required:
• Specimen identification number
• Patient Name & Date of Birth
• Social Security Number
• Name the person placing the verbal request and the phone number the results may be called to direct result transmission to a client’s facility via fax, printer, or electronic system is considered to be a confidential transmission. Clients are requested to enforce appropriate confidentiality requirements on the receiving end.

Critical Value Reporting
ADX Arizona Dermatopathology defines the initial diagnosis of melanoma, Merkel cell carcinoma, and metastatic disease, as well as some infectious conditions as critical results. We will ensure your critical results are sent to your office through the routine route, but also will perform a secondary notification to your practice. In most instances, our dermatopathologists will call your office personally with the critical result to ensure a secondary means of communication.

In the event that critical results are obtained from a facility during hours or days when they are not open, a phone call will be placed during the next available business day.

Medical Release Authorization:
Testing results will only be released to authorized individuals. Patient results will automatically be reported to the ordering physician via the reporting mechanism chosen for your office.

If patient results need to be reported to a secondary referring physician and/or facility, a Medical Release Authorization must be completed. Patient results will not be released to a secondary referring physician or facility without a
Medical Release Authorization form on file at ADX Arizona Dermatopathology Laboratory.

Results will only be released to a patient when a completed Medical Release Authorization form is on file.

Compliance Statements
Analyte Specific Reagents (ASR) are used in many laboratory tests necessary for standard medical care. This test was developed and its performance characteristics determined by ADX Arizona Dermatopathology Laboratory. It has not been cleared or approved by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical laboratory testing.